Clario, a leading provider of endpoint data solutions to the clinical trial industry, announces they have entered into a definitive agreement to acquire the eCOA business of WCG, a leader in providing solutions that measurably improve and accelerate clinical research. Electronic clinical outcomes assessments (eCOA), in addition to paper assessments, are used to evaluate the safety and efficacy of new drugs by measuring how a clinical trial participant feels or functions. WCG’s eCOA operations offer robust, full-service clinical expertise and specialized functionality, particularly in neurology, psychiatry, neuropathic pain, and rare diseases.
Read the full article: Clario Enters into Definitive Agreement to Acquire WCG’s eCOA Business //
Source: https://www.prnewswire.com/news-releases/clario-enters-into-definitive-agreement-to-acquire-wcgs-ecoa-business-302397392.html